211. 左心低形成症候群 Hypoplastic left heart syndrome Clinical trials / Disease details

臨床試験数 : 22 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

diseases per page:

Showing 1 to 10 of 22 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04925024 (ClinicalTrials.gov)	June 25, 2021	8/6/2021	Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase IIb Cli ...	Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase IIb Cli ...	Hypoplastic Left Heart Syndrome	Biological: Lomecel-B medicinal signaling cells	Ann & Robert H Lurie Children's Hospital of Chicago	National Heart, Lung, and Blood Institute (NHLBI);The University of Texas Health Science Center, Hou ...	Recruiting	N/A	12 Months	All	38	Phase 2	United States
2	NCT04181255 (ClinicalTrials.gov)	February 25, 2020	26/11/2019	Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy	The Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy Following Deep Hypothermic Circ ...	Congenital Heart Disease;Hypoplastic Left Heart Syndrome	Drug: Curosurf;Drug: Sham	University of Michigan	Chiesi Farmaceutici S.p.A.	Recruiting	N/A	12 Weeks	All	60	Phase 1	United States
3	NCT04090697 (ClinicalTrials.gov)	December 20, 2019	4/4/2019	Use of Oxandrolone to Promote Growth in Infants With HLHS	Use of Oxandrolone to Promote Growth in Infants With Hypoplastic Left Heart Syndrome: A Phase I/II P ...	Hypoplastic Left Heart;Congenital Heart Disease	Drug: Oxandrolone	HealthCore-NERI	NULL	Recruiting	N/A	14 Days	All	100	Phase 1/Phase 2	United States;Canada
4	NCT03406884 (ClinicalTrials.gov)	October 16, 2019	20/12/2017	The CHILD Trial: Hypoplastic Left Heart Syndrome Study.	Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Lab ...	Hypoplastic Left Heart Syndrome	Biological: c-kit+ cells	University of Miami	NULL	Recruiting	1 Day	21 Days	All	32	Phase 1	United States
5	NCT03779711 (ClinicalTrials.gov)	June 6, 2019	4/12/2018	Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgic ...	Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear ...	Hypoplastic Left Heart Syndrome	Biological: Autologous (self) mononuclear cells derived from umbilical cord blood;Procedure: Stage I ...	Timothy J Nelson, MD, PhD	University of Oklahoma;Children's Hospital of Philadelphia;Children's Hospital Los Angeles;Children' ...	Active, not recruiting	N/A	12 Months	All	95	Phase 2	United States
6	NCT03525418 (ClinicalTrials.gov)	February 21, 2018	19/2/2018	Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)	Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)	HLHS	Biological: Longeveron Mesenchymal Stem Cells	Longeveron Inc.	NULL	Completed	N/A	1 Year	All	10	Phase 1/Phase 2	United States
7	NCT03136835 (ClinicalTrials.gov)	February 2, 2018	28/10/2015	Maternal Hyperoxygenation in Congenital Heart Disease	Maternal Hyperoxygenation in Congenital Heart Disease	Hypoplastic Left Heart Syndrome	Drug: Maternal Hyperoxygenation	The Hospital for Sick Children	NULL	Recruiting	18 Years	N/A	Female	20	Phase 1/Phase 2	Canada
8	NCT03079401 (ClinicalTrials.gov)	November 27, 2017	8/3/2017	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Hypoplastic Left Heart Syndrome;Atrioventricular Canal	Biological: MPC; rexlemestrocel-L	Boston Children's Hospital	NULL	Active, not recruiting	N/A	5 Years	All	19	Phase 1/Phase 2	United States
9	NCT02781922 (ClinicalTrials.gov)	June 2016	19/5/2016	Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)	Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Su ...	Hypoplastic Left Heart Syndrome;Single Ventricle	Genetic: Autologous cardiac stem cells (JRM-001)	Metcela Inc.	NULL	Recruiting	0 Years	6 Years	All	40	Phase 3	Japan
10	NCT03147014 (ClinicalTrials.gov)	January 1, 2016	4/5/2017	Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease	Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease	Hypoplastic Left Heart Syndrome;Aortic Coarctation;Atrial Septal Aneurysm	Biological: Maternal hyperoxygenation	Beijing Anzhen Hospital	NULL	Recruiting	N/A	N/A	Female	600	N/A	China

First Previous1 2 3Next Last